Phospholipase A2 enzymes (PLA2s) has been found to be significantly overexpressed in various tumour tissues, including colorectal cancer, prostate cancer and gastric cancer, and patients with higher PLA2 expression have a poor prognosis [6]. This evidence concerns the gene PLA2G2A and prostate carcinoma.